Hemolytic uremic syndrome, atypical

Search Trials
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy – ACE Inhibitor Therapy Trial
Status:
Completed
Last Changed:
May 4, 2015
First Changed:
May 4, 2015
Disease(s):
Myocardial Fibrosis
Intervention(s):
Enalapril
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Terminated
Last Changed:
Jan 14, 2020
First Changed:
Jan 12, 2016
Disease(s):
Muscular Dystrophy
Intervention(s):
Tadalafil 20 MGbeetroot juice extract
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Status:
Completed
Last Changed:
Feb 3, 2016
First Changed:
Aug 13, 2013
Disease(s):
Other Diseases or Conditions
Intervention(s):
sleep parametersHormonal profileInflammatory profileCardiovascular profileMetabolic profile
The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status:
Completed
Last Changed:
Mar 10, 2017
First Changed:
Dec 31, 2012
Disease(s):
Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention(s):
Eculizumab
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Status:
Completed
Last Changed:
Jul 23, 2015
First Changed:
Feb 16, 2009
Disease(s):
Atypical Hemolytic Uremic Syndrome
Intervention(s):
Eculizumab
Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment
Status:
Terminated
Last Changed:
Jan 2, 2020
First Changed:
Nov 25, 2015
Disease(s):
Atypical Hemolytic Uremic Syndrome
Intervention(s):
Eculizumab
Complement Inhibition in aHUS Dialysis Patients
Status:
Terminated
Last Changed:
Nov 14, 2017
First Changed:
Jun 8, 2015
Disease(s):
Atypical Hemolytic Uremic Syndrome
Intervention(s):
CCX168
aHUS Observational Long Term Follow-Up
Status:
Terminated
Last Changed:
Feb 24, 2017
First Changed:
Jan 31, 2012
Disease(s):
Atypical Hemolytic Uremic Syndrome

Connect. Empower. Inspire.